These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 32202341)

  • 21. Endogenous CD4(+) CD25(+) regulatory T cells have a limited role in the control of Trypanosoma cruzi infection in mice.
    Kotner J; Tarleton R
    Infect Immun; 2007 Feb; 75(2):861-9. PubMed ID: 17101658
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IL-10 participates in the expansion and functional activation of CD8
    Pino-Martínez AM; Miranda CG; Batalla EI; González-Cappa SM; Alba Soto CD
    J Leukoc Biol; 2019 Jan; 105(1):163-175. PubMed ID: 30371945
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Contribution of NK, NK T, gamma delta T, and alpha beta T cells to the gamma interferon response required for liver protection against Trypanosoma cruzi.
    Sardinha LR; Elias RM; Mosca T; Bastos KR; Marinho CR; D'Império Lima MR; Alvarez JM
    Infect Immun; 2006 Apr; 74(4):2031-42. PubMed ID: 16552032
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In the Acute Phase of
    de Lima Pereira Dos Santos C; Vacani-Martins N; Cascabulho CM; Pereira MCS; Crispe IN; Henriques-Pons A
    Front Immunol; 2022; 13():868574. PubMed ID: 35720410
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Trypanosoma cruzi Infection Imparts a Regulatory Program in Dendritic Cells and T Cells via Galectin-1-Dependent Mechanisms.
    Poncini CV; Ilarregui JM; Batalla EI; Engels S; Cerliani JP; Cucher MA; van Kooyk Y; González-Cappa SM; Rabinovich GA
    J Immunol; 2015 Oct; 195(7):3311-24. PubMed ID: 26324777
    [TBL] [Abstract][Full Text] [Related]  

  • 26. GP 50/55, a membrane antigen of Trypanosoma cruzi involved in autoimmunity and immunosuppression.
    Hernández-Munaín C; De Diego JL; Bonay P; Gironés N; Fresno M
    Biol Res; 1993; 26(1-2):209-18. PubMed ID: 7670533
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Initial induction of immunity, followed by suppression of responses to parasite antigens during Trypanosoma cruzi infection of mice.
    Tarleton RL; Scott DW
    Parasite Immunol; 1987 Sep; 9(5):579-89. PubMed ID: 2960943
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Trypanosoma cruzi: maintenance of parasite-specific T cell responses in lymph nodes during the acute phase of the infection.
    Curotto de Lafaille MA; Barbosa de Oliveira LC; Lima GC; Abrahamsohn IA
    Exp Parasitol; 1990 Feb; 70(2):164-74. PubMed ID: 2105229
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Trypanosoma cruzi 80 kDa prolyl oligopeptidase (Tc80) as a novel immunogen for Chagas disease vaccine.
    Bivona AE; Sánchez Alberti A; Matos MN; Cerny N; Cardoso AC; Morales C; González G; Cazorla SI; Malchiodi EL
    PLoS Negl Trop Dis; 2018 Mar; 12(3):e0006384. PubMed ID: 29601585
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Suppression by Trypanosoma cruzi of T-cell receptor expression by activated human lymphocytes.
    Sztein MB; Kierszenbaum F
    Immunology; 1992 Oct; 77(2):277-83. PubMed ID: 1427979
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Immune response to Trypanosoma cruzi. An approach to the pathogenesis of Chagas' disease].
    Braun M; de Titto E
    Acta Physiol Pharmacol Latinoam; 1985; 35(1):1-47. PubMed ID: 2932884
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Involvement of accessory cells in the Trypanosoma cruzi-induced inhibition of the polyclonal response of T lymphocytes.
    Motrán C; Gruppi A; Vullo CM; Pistoresi-Palencia MC; Serra HM
    Parasite Immunol; 1996 Jan; 18(1):43-8. PubMed ID: 9223155
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Trypanosoma cruzi-induced molecular mimicry and Chagas' disease.
    Gironès N; Cuervo H; Fresno M
    Curr Top Microbiol Immunol; 2005; 296():89-123. PubMed ID: 16323421
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dendritic cells devoid of IL-10 induce protective immunity against the protozoan parasite Trypanosoma cruzi.
    Alba Soto CD; Solana ME; Poncini CV; Pino-Martinez AM; Tekiel V; González-Cappa SM
    Vaccine; 2010 Oct; 28(46):7407-13. PubMed ID: 20850535
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunoendocrine dysbalance during uncontrolled T. cruzi infection is associated with the acquisition of a Th-1-like phenotype by Foxp3(+) T cells.
    González FB; Villar SR; Fernández Bussy R; Martin GH; Pérol L; Manarin R; Spinelli SV; Pilon C; Cohen JL; Bottasso OA; Piaggio E; Pérez AR
    Brain Behav Immun; 2015 Mar; 45():219-32. PubMed ID: 25483139
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Coculture of human peripheral blood mononuclear cells with Trypanosoma cruzi leads to proliferation of lymphocytes and cytokine production.
    Van Voorhis WC
    J Immunol; 1992 Jan; 148(1):239-48. PubMed ID: 1727869
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Trypanosoma cruzi infection induces differential modulation of costimulatory molecules and cytokines by monocytes and T cells from patients with indeterminate and cardiac Chagas' disease.
    Souza PE; Rocha MO; Menezes CA; Coelho JS; Chaves AC; Gollob KJ; Dutra WO
    Infect Immun; 2007 Apr; 75(4):1886-94. PubMed ID: 17283096
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evasion of immune responses by Trypanosoma cruzi, the etiological agent of Chagas disease.
    DosReis GA
    Braz J Med Biol Res; 2011 Feb; 44(2):84-90. PubMed ID: 21243314
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Human Trypanosome Suppresses CD8+ T Cell Priming by Dendritic Cells through the Induction of Immune Regulatory CD4+ Foxp3+ T Cells.
    Ersching J; Basso AS; Kalich VL; Bortoluci KR; Rodrigues MM
    PLoS Pathog; 2016 Jun; 12(6):e1005698. PubMed ID: 27332899
    [TBL] [Abstract][Full Text] [Related]  

  • 40. IL-17RA-Signaling Modulates CD8+ T Cell Survival and Exhaustion During
    Tosello Boari J; Araujo Furlan CL; Fiocca Vernengo F; Rodriguez C; Ramello MC; Amezcua Vesely MC; Gorosito Serrán M; Nuñez NG; Richer W; Piaggio E; Montes CL; Gruppi A; Acosta Rodríguez EV
    Front Immunol; 2018; 9():2347. PubMed ID: 30364284
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.